查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1397008

手术用布帘市场：按类型、按风险类型、按最终用户：2023-2032 年全球机会分析和产业预测

Surgical Drapes Market By Type (Reusable, Disposable), By Risk Type (Moderate (AAMI Level 3), High (AAMI Level 4), Others), By End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 236 Pages | 商品交期: 2-3个工作天内

价格

2022年，全球手术用布帘市场价值为15亿美元，预计2023年至2032年复合年增长率为3.6%，到2032年将达到21亿美元。

手术用布帘是医疗和手术环境中使用的无菌保护屏障，用于在手术过程中保持无菌。这些手术单通常由聚丙烯、棉或聚酯等机织或不织布製成，它们不仅可以防止微生物在患者皮肤和手术团队之间传播，而且还可以在手术周围提供清洁且受控的区域。网站。它旨在创造一个友好的环境。手术用布帘有各种形状和尺寸，以适应各种手术，只暴露必要的区域，同时保持覆盖。手术单上有黏剂和屏障，可以进入需要治疗的特定区域。这些手术单透过最大限度地减少手术部位污染的风险、防止体液溢出和保持无菌来预防手术部位感染至关重要。

手术数量的增加和医院获得性感染（HAI）的迅速增加是手术用布帘市场的主要驱动因素。 HAI 是住院病患发病和死亡的主要原因。例如，根据世界卫生组织 (WHO) 的报告 (2021)，加护病房中高达 30% 的患者至少受到一种医院获得性感染 (HAI) 的影响。这种令人震惊的盛行率凸显了采取严格的感染控制措施的必要性，包括使用手术用布帘，以在医疗机构中创建和维持无菌环境。

此外，非政府组织和政府组织都在带头采取倡议，透过实施教育患者和医疗机构的计划和宣传活动来提高对感染控制措施的认识。因此，意识的提高加上建议使用手术用布帘的感染预防和控制指南的迅速采用预计将进一步推动市场成长。这些因素凸显了手术用布帘在降低感染风险和提高病人安全方面发挥的关键作用。

此外，对环境永续性的日益关注也推动了手术用布帘市场的发展。减少塑胶窗帘对环境影响的倡议是成长的关键驱动力。包括政府机构、行业领导者和医疗机构在内的各种相关人员都在积极支持永续性配合措施。这包括在手术单製造中推广使用环保材料，并鼓励负责任的处置做法，与全球配合措施使医疗保健变得越来越环保保持一致。我们正在这样做。例如，Molnlycke Health Care 等公司正在采取积极措施，减少基于化石的二氧化碳排放，促进整个供应链的永续性，增强製造流程，例如 BARRIER Universal ISCC。我是。这些趋势符合更广泛的全球环保医疗保健解决方案运动，并正在推动市场成长。

目录

第一章简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
      • 手术数量快速增加
      • 手术用布帘的技术进步
      • 政府措施的成长
    • 抑制因素
      • 主要企业之间的竞争
      • 产品召回
    • 机会
      • 新兴市场的成长机会

第四章手术用布帘市场：依类型

  • 概述
  • 可重复使用的
  • 一次性的

第五章手术用布帘市场：依风险类型

  • 概述
  • 中（AAMI 3 级）
  • 海拔高度（AAMI 4 级）
  • 其他的

第六章手术用布帘市场：依最终使用者分类

  • 概述
  • 医院
  • 门诊手术中心
  • 其他的

第七章手术用布帘市场：按地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • 南非
    • 沙乌地阿拉伯
    • 其他的

第八章 竞争形势

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争仪表板
  • 竞争热图
  • 2022年主要企业定位

第九章 公司简介

  • Molnlycke Health Care AB
  • Paul Hartmann AG
  • Narang Medical Limited
  • Standard Textile Co., Inc.
  • Delta Med SpA
  • Medline Industries Inc.
  • Priontex
  • Medica Europe BV
  • Cardinal Health
  • 3M Company
Product Code: A03454

The global surgical drapes market was valued at $1.5 billion in 2022, and is projected to reach $2.1 billion by 2032, growing at a CAGR of 3.6% from 2023 to 2032. Surgical drapes are sterile and protective barriers used in medical and surgical settings to maintain aseptic conditions during procedures. These drapes are typically made from woven and non-woven materials, such as polypropylene, cotton and polyester, and are designed to prevent the transfer of microorganisms between the patient's skin and the surgical team, as well as to create a clean, controlled environment around the surgical site. Surgical drapes are available in various shapes and sizes to accommodate different procedures, ensuring that only the necessary area is exposed while the rest remains covered. They feature adhesive or fenestrations to provide access to the specific area requiring treatment. These drapes are essential in preventing surgical site infections by minimizing the risk of contamination, controlling fluid runoff, and maintaining a sterile field, which is crucial for successful surgical outcomes and patient safety.

The increase in number of surgeries and surge in hospital-acquired infections (HAIs) are major drivers of the surgical drapes market. HAIs are the leading cause of morbidity and mortality in hospitalized patients. For instance, the report of World Health Organization (WHO) 2021, stated that, up to 30% of patients are affected by at least one hospital acquired infections (HAIs) in intensive care units. This alarming prevalence underscores the need for stringent infection control measures, including the use of surgical drapes, to create and maintain sterile environments in healthcare settings.

Moreover, both non-governmental and government organizations are spearheading initiatives aimed at increasing awareness of infection control measures by conduct programs and campaigns to educate patients and healthcare facilities. Thus, increased awareness, combined with the surge in adoption of infection prevention and control guidelines that recommend the use of surgical drapes, is anticipated to further fuel the market growth. These factors collectively highlight the pivotal role of surgical drapes in mitigating infection risks and enhancing patient safety.

Moreover, the market for surgical drapes is benefiting from a growing emphasis on environmental sustainability. The move towards reducing the environmental impact of plastic drapes is a significant driver propelling the growth. Various stakeholders, including government organizations, industry leaders, and healthcare facilities, are actively endorsing sustainability initiatives. This involves promoting the use of eco-friendly materials in drape manufacturing and encouraging responsible disposal practices, aligning with global efforts to make healthcare more environmentally conscious and eco-friendly. For instance, companies like Molnlycke Health Care are taking proactive steps, enhancing manufacturing processes, such as BARRIER Universal ISCC, to reduce fossil-based CO2 emissions and promote sustainability throughout the supply chain. This trend aligns with the broader global movement towards environmentally conscious healthcare solutions and thus drive the market growth.

In addition, the key players are adopting strategic initiatives to foster growth, including expansion and product launches. For instance, in March 2022, Cardinal Health, a global manufacturer and distributor of medical and laboratory products announced the launch of the first surgical incise drape using industry-leading antiseptic Chlorhexidine Gluconate (CHG). Such innovative product launches and expansions are expected to be propelling market growth, as they address the evolving needs of healthcare professionals and enhance infection control measures, ultimately contributing to improved patient outcomes.

The surgical drapes market is segmented into type, risk type, end user and region. On the basis of type, the market is categorized into reusable and disposable. On the basis of risk type, the market is categorized into moderate (AAMI Level 3), high (AAMI Level 4) and others. On the basis of end user, the market is segregated into hospitals, ambulatory surgical centers and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global surgical drapes market include Molnlycke Health Care AB, Narang Medical Limited, Cardinal Health, Medline Industries Inc, Medica Europe BV, Priontex, Delta Med SpA Paul Hartmann AG, 3M Company and Standard Textile Co., Inc. The key players have adapted product launch as the strategies to enhance its product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the surgical drapes market analysis from 2022 to 2032 to identify the prevailing surgical drapes market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the surgical drapes market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global surgical drapes market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Technology Trend Analysis
  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Type

  • Reusable
  • Disposable

By Risk Type

  • Others
  • Moderate (AAMI Level 3)
  • High (AAMI Level 4)

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa,
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Narang Medical Limited
    • Delta Med SpA
    • Cardinal Health
    • Molnlycke Health Care AB
    • Priontex
    • Paul Hartmann AG
    • 3M Company
    • Medica Europe BV
    • Standard Textile Co., Inc.
    • Medline Industries Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. High bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Surge in number of surgeries
      • 3.4.1.2. Technological advancements in surgical drapes
      • 3.4.1.3. Growth in government initiatives for infection prevention and control
    • 3.4.2. Restraints
      • 3.4.2.1. Competition among the key players
      • 3.4.2.2. Product recalls
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging markets

CHAPTER 4: SURGICAL DRAPES MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Reusable
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Disposable
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: SURGICAL DRAPES MARKET, BY RISK TYPE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Moderate (AAMI Level 3)
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. High (AAMI Level 4)
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: SURGICAL DRAPES MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: SURGICAL DRAPES MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Risk Type
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Type
      • 7.2.5.1.2. Market size and forecast, by Risk Type
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Type
      • 7.2.5.2.2. Market size and forecast, by Risk Type
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Type
      • 7.2.5.3.2. Market size and forecast, by Risk Type
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Risk Type
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Type
      • 7.3.5.1.2. Market size and forecast, by Risk Type
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Type
      • 7.3.5.2.2. Market size and forecast, by Risk Type
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Type
      • 7.3.5.3.2. Market size and forecast, by Risk Type
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Type
      • 7.3.5.4.2. Market size and forecast, by Risk Type
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Type
      • 7.3.5.5.2. Market size and forecast, by Risk Type
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Type
      • 7.3.5.6.2. Market size and forecast, by Risk Type
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Risk Type
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Type
      • 7.4.5.1.2. Market size and forecast, by Risk Type
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Type
      • 7.4.5.2.2. Market size and forecast, by Risk Type
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Type
      • 7.4.5.3.2. Market size and forecast, by Risk Type
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Type
      • 7.4.5.4.2. Market size and forecast, by Risk Type
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Type
      • 7.4.5.5.2. Market size and forecast, by Risk Type
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Type
      • 7.4.5.6.2. Market size and forecast, by Risk Type
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Risk Type
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Type
      • 7.5.5.1.2. Market size and forecast, by Risk Type
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. South Africa,
      • 7.5.5.2.1. Market size and forecast, by Type
      • 7.5.5.2.2. Market size and forecast, by Risk Type
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. Saudi Arabia
      • 7.5.5.3.1. Market size and forecast, by Type
      • 7.5.5.3.2. Market size and forecast, by Risk Type
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Type
      • 7.5.5.4.2. Market size and forecast, by Risk Type
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Molnlycke Health Care AB
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Paul Hartmann AG
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Narang Medical Limited
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. Standard Textile Co., Inc.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
  • 9.5. Delta Med SpA
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
  • 9.6. Medline Industries Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. Priontex
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Medica Europe BV
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. Cardinal Health
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
    • 9.9.7. Key strategic moves and developments
  • 9.10. 3M Company
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. SURGICAL DRAPES MARKET FOR REUSABLE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. SURGICAL DRAPES MARKET FOR DISPOSABLE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 05. SURGICAL DRAPES MARKET FOR MODERATE (AAMI LEVEL 3), BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. SURGICAL DRAPES MARKET FOR HIGH (AAMI LEVEL 4), BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. SURGICAL DRAPES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. GLOBAL SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 09. SURGICAL DRAPES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. SURGICAL DRAPES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. SURGICAL DRAPES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. SURGICAL DRAPES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA SURGICAL DRAPES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 17. U.S. SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. U.S. SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 19. U.S. SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. CANADA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 21. CANADA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 22. CANADA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. MEXICO SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. EUROPE SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE SURGICAL DRAPES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 30. GERMANY SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. GERMANY SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. FRANCE SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. UK SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. UK SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 38. UK SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. ITALY SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 40. ITALY SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 41. ITALY SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. SPAIN SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. REST OF EUROPE SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 46. REST OF EUROPE SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. ASIA-PACIFIC SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 49. ASIA-PACIFIC SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC SURGICAL DRAPES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 52. JAPAN SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. JAPAN SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 54. JAPAN SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. CHINA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 56. CHINA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 57. CHINA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. INDIA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 59. INDIA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 60. INDIA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. AUSTRALIA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. AUSTRALIA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 63. AUSTRALIA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH KOREA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH KOREA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH KOREA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. REST OF ASIA-PACIFIC SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. LAMEA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 71. LAMEA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 72. LAMEA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. LAMEA SURGICAL DRAPES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 74. BRAZIL SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 75. BRAZIL SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 76. BRAZIL SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. SOUTH AFRICA, SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 78. SOUTH AFRICA, SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 79. SOUTH AFRICA, SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. SAUDI ARABIA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 81. SAUDI ARABIA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 82. SAUDI ARABIA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. REST OF LAMEA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 84. REST OF LAMEA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
  • TABLE 85. REST OF LAMEA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. MOLNLYCKE HEALTH CARE AB: KEY EXECUTIVES
  • TABLE 87. MOLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT
  • TABLE 88. MOLNLYCKE HEALTH CARE AB: PRODUCT SEGMENTS
  • TABLE 89. MOLNLYCKE HEALTH CARE AB: PRODUCT PORTFOLIO
  • TABLE 90. PAUL HARTMANN AG: KEY EXECUTIVES
  • TABLE 91. PAUL HARTMANN AG: COMPANY SNAPSHOT
  • TABLE 92. PAUL HARTMANN AG: PRODUCT SEGMENTS
  • TABLE 93. PAUL HARTMANN AG: PRODUCT PORTFOLIO
  • TABLE 94. NARANG MEDICAL LIMITED: KEY EXECUTIVES
  • TABLE 95. NARANG MEDICAL LIMITED: COMPANY SNAPSHOT
  • TABLE 96. NARANG MEDICAL LIMITED: PRODUCT SEGMENTS
  • TABLE 97. NARANG MEDICAL LIMITED: PRODUCT PORTFOLIO
  • TABLE 98. STANDARD TEXTILE CO., INC.: KEY EXECUTIVES
  • TABLE 99. STANDARD TEXTILE CO., INC.: COMPANY SNAPSHOT
  • TABLE 100. STANDARD TEXTILE CO., INC.: PRODUCT SEGMENTS
  • TABLE 101. STANDARD TEXTILE CO., INC.: PRODUCT PORTFOLIO
  • TABLE 102. DELTA MED SPA: KEY EXECUTIVES
  • TABLE 103. DELTA MED SPA: COMPANY SNAPSHOT
  • TABLE 104. DELTA MED SPA: PRODUCT SEGMENTS
  • TABLE 105. DELTA MED SPA: PRODUCT PORTFOLIO
  • TABLE 106. MEDLINE INDUSTRIES INC.: KEY EXECUTIVES
  • TABLE 107. MEDLINE INDUSTRIES INC.: COMPANY SNAPSHOT
  • TABLE 108. MEDLINE INDUSTRIES INC.: PRODUCT SEGMENTS
  • TABLE 109. MEDLINE INDUSTRIES INC.: PRODUCT PORTFOLIO
  • TABLE 110. PRIONTEX: KEY EXECUTIVES
  • TABLE 111. PRIONTEX: COMPANY SNAPSHOT
  • TABLE 112. PRIONTEX: PRODUCT SEGMENTS
  • TABLE 113. PRIONTEX: PRODUCT PORTFOLIO
  • TABLE 114. MEDICA EUROPE BV: KEY EXECUTIVES
  • TABLE 115. MEDICA EUROPE BV: COMPANY SNAPSHOT
  • TABLE 116. MEDICA EUROPE BV: PRODUCT SEGMENTS
  • TABLE 117. MEDICA EUROPE BV: PRODUCT PORTFOLIO
  • TABLE 118. CARDINAL HEALTH: KEY EXECUTIVES
  • TABLE 119. CARDINAL HEALTH: COMPANY SNAPSHOT
  • TABLE 120. CARDINAL HEALTH: PRODUCT SEGMENTS
  • TABLE 121. CARDINAL HEALTH: PRODUCT PORTFOLIO
  • TABLE 122. CARDINAL HEALTH: KEY STRATERGIES
  • TABLE 123. 3M COMPANY: KEY EXECUTIVES
  • TABLE 124. 3M COMPANY: COMPANY SNAPSHOT
  • TABLE 125. 3M COMPANY: PRODUCT SEGMENTS
  • TABLE 126. 3M COMPANY: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. SURGICAL DRAPES MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF SURGICAL DRAPES MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN SURGICAL DRAPES MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN SURGICAL DRAPES MARKET (2023-2032)
  • FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 07. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. HIGH BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL SURGICAL DRAPES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. SURGICAL DRAPES MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF SURGICAL DRAPES MARKET FOR REUSABLE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF SURGICAL DRAPES MARKET FOR DISPOSABLE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. SURGICAL DRAPES MARKET, BY RISK TYPE, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF SURGICAL DRAPES MARKET FOR MODERATE (AAMI LEVEL 3), BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF SURGICAL DRAPES MARKET FOR HIGH (AAMI LEVEL 4), BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF SURGICAL DRAPES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. SURGICAL DRAPES MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF SURGICAL DRAPES MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF SURGICAL DRAPES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF SURGICAL DRAPES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. SURGICAL DRAPES MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 23. U.S. SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. CANADA SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. MEXICO SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. GERMANY SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. FRANCE SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. UK SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. ITALY SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. SPAIN SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. REST OF EUROPE SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. JAPAN SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. CHINA SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. INDIA SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. AUSTRALIA SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. SOUTH KOREA SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. REST OF ASIA-PACIFIC SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. BRAZIL SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. SOUTH AFRICA, SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. SAUDI ARABIA SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. REST OF LAMEA SURGICAL DRAPES MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. TOP WINNING STRATEGIES, BY YEAR (2022)
  • FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT (2022)
  • FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY (2022)
  • FIGURE 45. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 46. COMPETITIVE DASHBOARD
  • FIGURE 47. COMPETITIVE HEATMAP: SURGICAL DRAPES MARKET
  • FIGURE 48. TOP PLAYER POSITIONING, 2022
  • FIGURE 49. MOLNLYCKE HEALTH CARE AB: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 50. MOLNLYCKE HEALTH CARE AB: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 51. MOLNLYCKE HEALTH CARE AB: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 52. PAUL HARTMANN AG: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 53. PAUL HARTMANN AG: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 54. PAUL HARTMANN AG: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 55. CARDINAL HEALTH: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 56. CARDINAL HEALTH: REVENUE SHARE BY SEGMENT, 2023 (%)
  • FIGURE 57. CARDINAL HEALTH: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 58. 3M COMPANY: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 59. 3M COMPANY: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 60. 3M COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 61. 3M COMPANY: REVENUE SHARE BY REGION, 2022 (%)